$73.54
1.121.55%
At Close: -
$74.25
0.710.97%
After Hours: 7:29 PM EDT
15 minutes delayed
Comments
Loading...
Intra-Cellular Therapies (ITCI) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestIntra-Cellular Therapies (NASDAQ:ITCI) Stock Quotes, Forecast and News Summary
Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.
| Open | $74.89 |
| Close | $73.54 |
| Volume / Avg. | 840.11K / 1.01M |
| Day Range | $73.02 - $76.12 |
| 52 Wk Range | 45.50 - 84.89 |
| Market Cap | $7.85B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 49 |
| Short Interest | 2.76% |
| Days to Cover | 3.41 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Intra-Cellular Therapies Inc
Sector
Health Care
Industry
Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating d...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Intra-Cellular Therapies (ITCI) stock?
You can purchase shares of Intra-Cellular Therapies (NASDAQ:ITCI) through any online brokerage.
Who are Intra-Cellular Therapies (ITCI) competitors?
Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
What is the forecast, or price target, for Intra-Cellular Therapies (ITCI) stock?
Intra-Cellular Therapies has a consensus price target of $91.31.
What is the current price for Intra-Cellular Therapies (ITCI)?
The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $74.25 last updated September 6, 2024 at 7:29 PM EDT.
Does Intra-Cellular Therapies (ITCI) pay a dividend?
There are no upcoming dividends for Intra-Cellular Therapies.
When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?
Intra-Cellular Therapies’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Intra-Cellular Therapies (ITCI) going to split?
There is no upcoming split for Intra-Cellular Therapies.
What sector and industry does Intra-Cellular Therapies (ITCI) operate in?
Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.